These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 3292326)

  • 21. Pharmacokinetics of intravenous insulin delivery in humans with type 1 diabetes.
    Hipszer B; Joseph J; Kam M
    Diabetes Technol Ther; 2005 Feb; 7(1):83-93. PubMed ID: 15738706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin glulisine, insulin lispro and regular human insulin show comparable end-organ metabolic effects: an exploratory study.
    Horvath K; Bock G; Regittnig W; Bodenlenz M; Wutte A; Plank J; Magnes C; Sinner F; Fürst-Recktenwald S; Theobald K; Pieber TR
    Diabetes Obes Metab; 2008 Jun; 10(6):484-91. PubMed ID: 17764465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin kinetics in type I diabetic patients treated by continuous intraperitoneal insulin infusion: influence of anti-insulin antibodies.
    Lassmann-Vague V; Belicar P; Alessis C; Raccah D; Vialettes B; Vague P
    Diabet Med; 1996 Dec; 13(12):1051-5. PubMed ID: 8973887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the pharmacokinetic and pharmacodynamic profiles of biphasic insulin aspart 50 and 30 in patients with type 2 diabetes mellitus: a single-center, randomized, double-blind, two-period, crossover trial in Japan.
    Hirao K; Maeda H; Urata S; Takisawa Y; Hirao S; Sasako T; Sasaki T
    Clin Ther; 2007 May; 29(5):927-934. PubMed ID: 17697911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diminished insulin clearance during late pregnancy in patients with type I diabetes mellitus.
    Björklund AO; Adamson UK; Lins PE; Westgren LM
    Clin Sci (Lond); 1998 Sep; 95(3):317-23. PubMed ID: 9730851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of pharmacokinetic and pharmacodynamic properties of single-dose oral insulin spray and subcutaneous insulin injection in healthy subjects using the euglycemic clamp technique.
    Cernea S; Kidron M; Wohlgelernter J; Modi P; Raz I
    Clin Ther; 2004 Dec; 26(12):2084-91. PubMed ID: 15823772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subcutaneous insulin substitution in insulin-dependent diabetes mellitus. Pharmacokinetic and pharmacodynamic studies.
    Olsson PO
    Acta Med Scand Suppl; 1987; 718():1-78. PubMed ID: 3321929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of portal and peripheral insulin delivery on carbohydrate and lipid metabolism in a miniature pig model of human IDDM.
    Canavan JP; Flecknell PA; New JP; Alberti KG; Home PD
    Diabetologia; 1997 Oct; 40(10):1125-34. PubMed ID: 9349592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dose-response relationship of an oral insulin spray in six patients with type 1 diabetes: a single-center, randomized, single-blind, 5-way crossover study.
    Cernea S; Kidron M; Wohlgelernter J; Raz I
    Clin Ther; 2005 Oct; 27(10):1562-70. PubMed ID: 16330292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Products of therapeutic insulins in the blood of insulin-dependent (type I) diabetic patients.
    Robbins DC; Shoelson SE; Tager HS; Mead PM; Gaynor DH
    Diabetes; 1985 May; 34(5):510-9. PubMed ID: 3886464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pharmacokinetics of insulin after continuous subcutaneous infusion or bolus subcutaneous injection in diabetic patients.
    Kobayashi T; Sawano S; Itoh T; Kosaka K; Hirayama H; Kasuya Y
    Diabetes; 1983 Apr; 32(4):331-6. PubMed ID: 6339306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of human regular and lispro insulins after interruption of continuous subcutaneous insulin infusion and in the treatment of acutely decompensated IDDM.
    Attia N; Jones TW; Holcombe J; Tamborlane WV
    Diabetes Care; 1998 May; 21(5):817-21. PubMed ID: 9589247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interstitial muscle insulin and glucose levels in normal and insulin-resistant Zucker rats.
    Holmäng A; Mimura K; Björntorp P; Lönnroth P
    Diabetes; 1997 Nov; 46(11):1799-804. PubMed ID: 9356029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose-response characteristics of insulin action on glucose metabolism: a non-steady-state approach.
    Natali A; Gastaldelli A; Camastra S; Sironi AM; Toschi E; Masoni A; Ferrannini E; Mari A
    Am J Physiol Endocrinol Metab; 2000 May; 278(5):E794-801. PubMed ID: 10780934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased insulin clearance as a feature of essential hypertension.
    Salvatore T; Cozzolino D; Giunta R; Giugliano D; Torella R; D'Onofrio F
    J Clin Endocrinol Metab; 1992 Jan; 74(1):144-9. PubMed ID: 1727814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prandial glycaemia after a carbohydrate-rich meal in type I diabetic patients: using the rapid acting insulin analogue [Lys(B28), Pro(B29)] human insulin.
    Heinemann L; Heise T; Wahl LC; Trautmann ME; Ampudia J; Starke AA; Berger M
    Diabet Med; 1996 Jul; 13(7):625-9. PubMed ID: 8840095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The connection between the steady state (Vss) and terminal (Vbeta) volumes of distribution in linear pharmacokinetics and the general proof that Vbeta >/= Vss.
    Berezhkovskiy LM
    J Pharm Sci; 2007 Jun; 96(6):1638-52. PubMed ID: 17117429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of arterial hypotension after therapeutic dose of subcutaneous insulin in diabetic autonomic neuropathy.
    Porcellati F; Fanelli C; Bottini P; Epifano L; Rambotti AM; Lalli C; Pampanelli S; Scionti L; Santeusanio F; Brunetti P
    Diabetes; 1993 Jul; 42(7):1055-64. PubMed ID: 8513972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of FCE 22101 in man following different modes of administration.
    Lovering AM; White LO; Lewis DA; MacGowan AP; Routh KR; Pickin DM; Reeves DS
    J Antimicrob Chemother; 1989 Mar; 23 Suppl C():179-95. PubMed ID: 2732141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Technosphere/Insulin--proof of concept study with a new insulin formulation for pulmonary delivery.
    Steiner S; Pfützner A; Wilson BR; Harzer O; Heinemann L; Rave K
    Exp Clin Endocrinol Diabetes; 2002 Jan; 110(1):17-21. PubMed ID: 11835120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.